Evidence map›Paper›PMID 30853465›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2019

The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Jennifer L Whitwell, Peter Martin, Jonathan Graff-Radford, Mary M Machulda, Matthew L Senjem, Christopher G Schwarz, Stephen D Weigand, Anthony J Spychalla, Daniel A Drubach, Clifford R Jack and 2 more

Open access · greenAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Plasma eMTBR-tau243 as a disease biomarker across Alzheimer's disease clinical phenotypes.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Article
  4. AβJournal of Alzheimer's disease : JAD · 2025
    Article
  5. Article
  6. Article
  7. Investigating the feasibility ofAlzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Observational
  8. Relationships between PET and blood plasma biomarkers in corticobasal syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jennifer L WhitwellDepartment of Radiology, Mayo Clinic, Rochester MN, USA. Electronic address: Whitwell.jennifer@mayo.edu.
Peter MartinDepartment of Health Science Research, Mayo Clinic, Rochester MN, USA.
Jonathan Graff-RadfordDepartment of Neurology, Mayo Clinic, Rochester MN, USA.
Mary M MachuldaDepartment of Psychology and Psychiatry, Mayo Clinic, Rochester MN, USA.
Matthew L SenjemDepartment of Radiology, Mayo Clinic, Rochester MN, USA; Department of Information Technology, Mayo Clinic, Rochester MN, USA.
Christopher G SchwarzDepartment of Radiology, Mayo Clinic, Rochester MN, USA.
Stephen D WeigandDepartment of Health Science Research, Mayo Clinic, Rochester MN, USA.
Anthony J SpychallaDepartment of Radiology, Mayo Clinic, Rochester MN, USA.
Daniel A DrubachDepartment of Neurology, Mayo Clinic, Rochester MN, USA.
Clifford R JackDepartment of Radiology, Mayo Clinic, Rochester MN, USA.
Val J LoweDepartment of Radiology, Mayo Clinic, Rochester MN, USA.
Keith A JosephsDepartment of Neurology, Mayo Clinic, Rochester MN, USA.
Mayo Clinic in Arizona · USMayo Clinic in Florida · USMayo Clinic · US

Funding

Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal studyR01AG050603 · NIA · MAYO CLINIC ROCHESTER · PI WHITWELL, JENNIFER LOUISE · 2016 to 2025
$5.9M
Assessment of hyperphosphorylated tau PET binding in primary progressive aphasiaR21NS094684 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2016 to 2017
$417k
NIA NIH HHS R01 AG050603NINDS NIH HHS R21 NS094684
6 · The paper itself

Abstract

introductionLittle is known about the role of age on neurodegeneration and protein deposition in atypical variants of Alzheimer's disease (AD).

methodsRegional tau and β-amyloid positron emission tomography standard uptake value ratios and gray matter volumes were calculated in a cohort of 42 participants with atypical AD. The relationship between regional metrics and age was modeled using a Bayesian hierarchical linear model.

resultsAge was strongly associated with tau uptake across all cortical regions, particularly parietal, with greater uptake in younger participants. Younger age was associated with smaller parietal and lateral temporal volumes. Regional β-amyloid differed little by age. Age showed a stronger association with tau than volume and β-amyloid in all cortical regions. Age was not associated with cognitive performance. DISCUSSION: Age is an important determinant of severity of cortical tau uptake in atypical AD, with young participants more likely to show widespread and severe cortical tau uptake.

Indexed as

Alzheimer DiseaseAphasia, Primary ProgressivePositron-Emission TomographyAgedAge FactorsAmyloidAniline CompoundsAtrophyBrainCohort StudiesFemaleGray MatterHumansMaletau ProteinsThiazoles2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAmyloidAniline Compoundstau ProteinsThiazolesageAmyloidAV-1451Magnetic resonance imagingPittsburgh compound BPositron emission tomographytau

Identifiers

PMID30853465
PMCPMC6511453
OpenAlexW2922283453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.